[go: up one dir, main page]

AR025224A1 - Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma - Google Patents

Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma

Info

Publication number
AR025224A1
AR025224A1 ARP000104160A ARP000104160A AR025224A1 AR 025224 A1 AR025224 A1 AR 025224A1 AR P000104160 A ARP000104160 A AR P000104160A AR P000104160 A ARP000104160 A AR P000104160A AR 025224 A1 AR025224 A1 AR 025224A1
Authority
AR
Argentina
Prior art keywords
oxazolidinona
guanidina
amida
methods
same
Prior art date
Application number
ARP000104160A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of AR025224A1 publication Critical patent/AR025224A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Compuestos de amidina y guanidina oxazolidinona N-sustituidos que tienen la formula (1) en la cual los sustituyentes tienen los siguientes significadosindicados en la descripcion. Estos compuestos son utiles como agentes antibacterianos.
ARP000104160A 1999-08-12 2000-08-11 Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma AR025224A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14846999P 1999-08-12 1999-08-12
US09/621,819 US6297242B1 (en) 1999-08-12 2000-07-21 N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof

Publications (1)

Publication Number Publication Date
AR025224A1 true AR025224A1 (es) 2002-11-13

Family

ID=22525916

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104160A AR025224A1 (es) 1999-08-12 2000-08-11 Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma

Country Status (4)

Country Link
US (1) US6297242B1 (es)
AR (1) AR025224A1 (es)
AU (1) AU6892900A (es)
WO (1) WO2001042229A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US7179912B2 (en) * 2000-09-01 2007-02-20 Icos Corporation Materials and methods to potentiate cancer treatment
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
AR045690A1 (es) 2003-06-03 2005-11-09 Rib X Pharmaceuticals Inc Compuestos biaril heterociclicos y metodos para preparar y utilizar los mismos
EP1713785A1 (en) 2003-12-17 2006-10-25 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
US8399660B2 (en) 2005-06-08 2013-03-19 Rib-X Pharmaceuticals, Inc. Process for the synthesis of triazoles
DE602006010702D1 (de) 2005-06-29 2010-01-07 Pharmacia & Upjohn Co Llc Homomorpholinoxazolidinone als antibakterielle mittel
EP1962774B1 (en) * 2005-11-01 2014-01-01 Mount Sinai School of Medicine Growth control of oral and superficial microorganisms using gallium compounds
WO2009009171A2 (en) 2007-04-02 2009-01-15 Sideromics, Llc Methods for preventing or treating infectious diseases using gallium compounds
US8507640B2 (en) 2010-08-19 2013-08-13 International Business Machines Corporation Methods of ring opening polymerization and catalysts therefor
WO2018170664A1 (en) * 2017-03-20 2018-09-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
WO2021184339A1 (en) 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8506659A1 (es) * 1983-06-07 1985-08-01 Du Pont Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
KR100257418B1 (ko) 1991-11-01 2000-05-15 로렌스 티. 마이젠헬더 치환된 아릴-및 헤테로아릴-페닐옥사졸리디논
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US6124334A (en) 1995-02-03 2000-09-26 Pharmacia & Upjohn Company Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
CN1075073C (zh) 1995-02-03 2001-11-21 法玛西雅厄普约翰美国公司 杂芳环取代的苯基噁唑烷酮抗菌剂
DK0828741T3 (da) 1995-05-11 2001-11-26 Upjohn Co Spirocykliske og bicykliske diazinyl- og carbazinyloxazolidinoner
MX9703040A (es) 1995-09-12 1997-07-31 Upjohn Co Antimicrobianos de feniloxazolidinona.
DE19601264A1 (de) 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
CZ298060B6 (cs) 1996-04-11 2007-06-06 Pharmacia & Upjohn Company Zpusob prípravy oxazolidinonu
DE69829846T2 (de) 1997-05-30 2006-02-23 Pharmacia & Upjohn Co. Llc, Kalamazoo Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität
KR20010021645A (ko) * 1997-07-11 2001-03-15 로렌스 티. 마이젠헬더 티아디아졸릴 및 옥사디아졸릴 페닐 옥사졸리디논 항균제
AU9001598A (en) * 1997-09-11 1999-03-29 Hokuriku Seiyaku Co. Ltd Thiourea derivatives
ES2182485T3 (es) * 1998-02-13 2003-03-01 Upjohn Co Derivados de aminofenil isosazolina sustituidos utiles como agentes antimicrobianos.
JPH11322729A (ja) 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
WO2000029396A1 (de) * 1998-11-17 2000-05-25 Bayer Aktiengesellschaft Neue substituierte phenyloxazolidon-derivate
JP2002531455A (ja) * 1998-11-27 2002-09-24 ファルマシア・アンド・アップジョン・カンパニー チオカルボニル官能基を有するオキサゾリジノン抗細菌剤

Also Published As

Publication number Publication date
WO2001042229A1 (en) 2001-06-14
US6297242B1 (en) 2001-10-02
AU6892900A (en) 2001-06-18

Similar Documents

Publication Publication Date Title
MX9700557A (es) Dihidrobenzofuranos.
ES2193508T3 (es) Ftalizinonas.
UY34152A (es) ?oxazolidinonas substituidas y su uso?.
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
NL350077I2 (nl) Cyprosulfamide
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
ECSP003699A (es) Inhibidores de fab i
MX9705296A (es) Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia.
DE69716925D1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
AR025224A1 (es) Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma
PT998460E (pt) Novos derivados de tetrazole
SE9702773D0 (sv) Novel compounds
BR9711586A (pt) Compostos e uso dos mesmo
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
AR024747A1 (es) Derivados de aminotiazoles, su preparacion y las composiciones farmaceuticas que los contienen.
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
DK1089625T3 (da) Ektoparasiticide midler
TR200101979T2 (tr) Antidepresyon tedavisi için 5HT1 antagonistleri.
ATE259813T1 (de) Triazolopyrimidinderivate

Legal Events

Date Code Title Description
FB Suspension of granting procedure